# Phio Pharmaceuticals Corp.: Form 8-K, filed Jun 8, 2018

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2018-06-08
- Accepted by EDGAR: Jun 8, 2018, 17:02 ET
- Period: 2018-06-05
- Accession: 0001683168-18-001640
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316818001640/rxi_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316818001640/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316818001640/rxi_8k.htm

Filed Jun 8, 2018.
Source: SEC EDGAR, the filing index for accession 0001683168-18-001640. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
